[
    {
        "answer": [
            "Route of administration",
            "Formulation",
            "Dosage form",
            "Food intake",
            "Stomach contents",
            "Gastrointestinal motility",
            "Liver function",
            "Renal function"
        ],
        "options": [
            "Route of administration",
            "Formulation",
            "Dosage form",
            "Food intake",
            "Stomach contents",
            "Gastrointestinal motility",
            "Liver function",
            "Renal function",
            "Cardiac disease",
            "Plasma protein binding"
        ],
        "question": "What factors affect the bioavailability of a drug?",
        "source": {
            "isbn": "978-1260117127",
            "page": 38,
            "paragraph_id": "978-1260117127-p38-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Oral",
            "Buccal",
            "Sublingual",
            "Topical",
            "Transdermal",
            "Intravenous",
            "Subcutaneous",
            "Intramuscular",
            "Rectal",
            "By inhalation"
        ],
        "options": [
            "Oral ingestion",
            "Intraperitoneal injection",
            "Rectal route",
            "Topical application",
            "Subcutaneous injection",
            "Inhalational therapy",
            "Transdermal delivery",
            "Buccal mucosa absorption",
            "Sublingual tablet dissolution",
            "Intraocular implantation",
            "Nasogastric tube feeding",
            "Intravascular infusion",
            "Intestinal perfusion"
        ],
        "question": "What methods can be utilized for administering drugs?",
        "source": {
            "isbn": "978-1260117127",
            "page": 25,
            "paragraph_id": "978-1260117127-p25-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Competitive inhibition",
            "Non-competitive inhibition",
            "Irreversible inhibition",
            "Physiological antagonism",
            "Interaction with ion channels",
            "Interaction with enzymes",
            "Interaction with neurotransmitters",
            "Binding to G-protein coupled receptors",
            "Ligand-gate ion channel receptors",
            "Nuclear hormone receptors",
            "Receptors linked to second messengers"
        ],
        "options": [
            "Competitive inhibition",
            "Non-competitive inhibition",
            "Irreversible inhibition",
            "Physiological antagonism",
            "Interaction with ion channels",
            "Binding to G-protein coupled receptors"
        ],
        "question": "What are the primary ways in which drugs can interact with their targets?",
        "source": {
            "isbn": "978-1260117127",
            "page": 30,
            "paragraph_id": "978-1260117127-p30-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Oral (swallowed)",
            "Buccal and sublingual (not swallowed)",
            "Intravenous",
            "Intramuscular",
            "Subcutaneous",
            "Rectal (suppository)",
            "Inhalation",
            "Topical",
            "Transdermal"
        ],
        "options": [
            "Oral (swallowed)",
            "Buccal and sublingual (not swallowed)",
            "Intravenous",
            "Intramuscular",
            "Subcutaneous",
            "Rectal (suppository)",
            "Inhalation",
            "Topical",
            "Transdermal"
        ],
        "question": "What are the common routes of drug administration?",
        "source": {
            "isbn": "978-1260117127",
            "page": 16,
            "paragraph_id": "978-1260117127-p16-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "coal tar",
            "aflatoxin",
            "dimethylnitrosamine",
            "nitrosamines",
            "urethane",
            "vinyl chloride",
            "polycyclic aromatic hydrocarbons"
        ],
        "options": [
            "thalidomide",
            "warfarin",
            "ethanol",
            "isotretinoin",
            "valproic acid",
            "glucocorticoids",
            "lithium",
            "androgens",
            "coal tar",
            "aflatoxin",
            "dimethylnitrosamine",
            "nitrosamines",
            "urethane",
            "vinyl chloride",
            "polycyclic aromatic hydrocarbons"
        ],
        "question": "What substances are identified in the passage as having known carcinogenic effects?",
        "source": {
            "isbn": "978-1260117127",
            "page": 20,
            "paragraph_id": "978-1260117127-p20-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Volume of distribution",
            "Clearance",
            "Half-life",
            "Bioavailability",
            "Area under the curve",
            "Peak and trough concentrations",
            "Minimum effective concentration",
            "First-pass effect",
            "Steady state"
        ],
        "options": [
            "Volume of distribution",
            "Clearance",
            "Half-life",
            "Bioavailability",
            "Area under the curve",
            "Peak and trough concentrations",
            "Minimum effective concentration",
            "First-pass effect",
            "Steady state"
        ],
        "question": "What are the key terms related to pharmacokinetics?",
        "source": {
            "isbn": "978-1260117127",
            "page": 36,
            "paragraph_id": "978-1260117127-p36-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Phase I reactions",
            "Phase II reactions"
        ],
        "options": [
            "Lipophilization reactions",
            "Hydroxylation reactions",
            "Conjugation reactions",
            "Oxidation reactions",
            "Reduction reactions"
        ],
        "question": "What types of reactions occur during drug metabolism?",
        "source": {
            "isbn": "978-1260117127",
            "page": 45,
            "paragraph_id": "978-1260117127-p45-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Passage through the gastric and intestinal contents",
            "Metabolism by enzymes in any of these tissues",
            "Expulsion by drug transporters back into the intestinal contents",
            "Excretion into the bile"
        ],
        "options": [
            "Passage through the gastric and intestinal contents",
            "Expulsion by drug transporters back into the intestinal contents",
            "Excretion into the urine",
            "Distribution throughout the body via systemic circulation",
            "Passage through the epithelium and other tissues of the intestinal wall",
            "Metabolism by enzymes in various tissues",
            "Entry into the portal vein",
            "Administration via injection"
        ],
        "question": "What are the factors contributing to the first-pass effect during oral administration?",
        "source": {
            "isbn": "978-1260117127",
            "page": 44,
            "paragraph_id": "978-1260117127-p44-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "CYP2C9",
            "CYP2C19",
            "CYP2D6",
            "CYP3A4, 3A5",
            "Dihydropyrimidine dehydrogenase (DPD)",
            "TPMT",
            "G6PD",
            "UGT1A1"
        ],
        "options": [
            "CYP2C9",
            "Dihydropyrimidine dehydrogenase (DPD)",
            "Beta-adrenoceptors",
            "UGT1A1",
            "Cyclooxygenase",
            "G6PD",
            "TPMT",
            "N-acetyl transferases",
            "Xanthine oxidase"
        ],
        "question": "What enzymes are listed as having associations with altered drug responses?",
        "source": {
            "isbn": "978-1260117127",
            "page": 53,
            "paragraph_id": "978-1260117127-p53-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Absorption",
            "Distribution",
            "Metabolism",
            "Elimination"
        ],
        "options": [
            "Absorption",
            "Distribution",
            "Metabolism",
            "Elimination",
            "Synthesis",
            "Oxidation"
        ],
        "question": "What are the main aspects involved in pharmacokinetics?",
        "source": {
            "isbn": "978-1260117127",
            "page": 55,
            "paragraph_id": "978-1260117127-p55-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Both muscarinic and nicotinic receptors"
        ],
        "options": [
            "Only nicotinic receptors",
            "Both muscarinic and nicotinic receptors",
            "Only adrenergic receptors",
            "Neither muscarinic nor nicotinic receptors"
        ],
        "question": "What types of receptors can cholinergic agents act upon?",
        "source": {
            "isbn": "978-1260117127",
            "page": 73,
            "paragraph_id": "978-1260117127-p73-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "M1",
            "M3"
        ],
        "options": [
            "M0",
            "M1",
            "M2",
            "M3",
            "M4",
            "M5",
            "M6",
            "M7"
        ],
        "question": "What types of muscarinic receptors are targeted clinically?",
        "source": {
            "isbn": "978-1260117127",
            "page": 79,
            "paragraph_id": "978-1260117127-p79-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Norepinephrine Transporter (NET)",
            "Dopamine Transporter (DAT)"
        ],
        "options": [
            "Serotonin Transporter",
            "Norepinephrine Transporter (NET)",
            "Dopamine Transporter (DAT)",
            "Glutamate Transporter",
            "Monoamine Oxidase (MAO)"
        ],
        "question": "What types of transporters are involved in the regulation of neurotransmitter levels?",
        "source": {
            "isbn": "978-1260117127",
            "page": 88,
            "paragraph_id": "978-1260117127-p88-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Beta1-receptor selectivity",
            "Partial agonist activity",
            "Local anesthetic action",
            "Lipid solubility"
        ],
        "options": [
            "Beta1-receptor selectivity",
            "Non-beta receptor blocking actions",
            "Lipid insolubility",
            "Membrane-stabilizing activity",
            "Alpha-receptor selectivity"
        ],
        "question": "What properties characterize beta-blocker classification?",
        "source": {
            "isbn": "978-1260117127",
            "page": 97,
            "paragraph_id": "978-1260117127-p97-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Alpha 1 (<X1)",
            "Alpha 2 (<X2)",
            "Beta 1 (~1)",
            "Beta 2 (~2)"
        ],
        "options": [
            "Alpha 1 (<X1)",
            "Alpha 2 (<X2)",
            "Beta 1 (~1)",
            "Beta 2 (~2)"
        ],
        "question": "Which types of adrenoreceptors are involved in various physiological responses?",
        "source": {
            "isbn": "978-1260117127",
            "page": 93,
            "paragraph_id": "978-1260117127-p93-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Cardiac glycosides",
            "Beta agonists",
            "Phosphodiesterase (PDE) inhibitors"
        ],
        "options": [
            "Cardiac glycosides",
            "Beta agonists",
            "Phosphodiesterase (PDE) inhibitors",
            "Vasodilators",
            "Digitalis",
            "Dobutaminelike substances"
        ],
        "question": "What categories of positive inotropic drugs are listed among the treatments for heart failure?",
        "source": {
            "isbn": "978-1260117127",
            "page": 122,
            "paragraph_id": "978-1260117127-p122-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ganglion-blocking drugs",
            "Postganglionic sympathetic nerve terminal blockers",
            "Adrenoceptor blockers"
        ],
        "options": [
            "Ganglion-blocking drugs",
            "Postganglionic sympathetic nerve terminal blockers",
            "Adrenoceptor blockers",
            "Direct-acting sympathomimetics",
            "Indirect-acting sympathomimetics"
        ],
        "question": "What types of sympathoplegic drugs are available for treating hypertension?",
        "source": {
            "isbn": "978-1260117127",
            "page": 106,
            "paragraph_id": "978-1260117127-p106-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Non-selective",
            "Beta1-selective",
            "Partial agonist"
        ],
        "options": [
            "Non-selective",
            "Beta1-selective",
            "Partial agonist"
        ],
        "question": "What are the types of beta-blockers discussed?",
        "source": {
            "isbn": "978-1260117127",
            "page": 141,
            "paragraph_id": "978-1260117127-p141-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Captopril",
            "Benazepril",
            "Enalapril",
            "Lisinopril"
        ],
        "options": [
            "Nifedipine",
            "Captopril",
            "Verapamil",
            "Hydralazine",
            "Minoxidil",
            "Nitroprusside",
            "Diazoxide",
            "Fenoldopam",
            "Aliskiren",
            "Benazepril",
            "Enalapril",
            "Lisinopril",
            "Losartan",
            "Candesartan",
            "Irbesartan"
        ],
        "question": "What drugs act as ACE inhibitors?",
        "source": {
            "isbn": "978-1260117127",
            "page": 112,
            "paragraph_id": "978-1260117127-p112-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Dihydropyridines",
            "Nondihydropyridines"
        ],
        "options": [
            "Dihydropyridines",
            "Nondihydropyridines",
            "Beta-blockers",
            "N-channel blockers",
            "Nitrate-based drugs"
        ],
        "question": "What types of calcium channel-blocking drugs are mentioned?",
        "source": {
            "isbn": "978-1260117127",
            "page": 118,
            "paragraph_id": "978-1260117127-p118-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Osmotic agents",
            "Potassium-sparing diuretics",
            "Thiazides",
            "Carbonic anhydrase inhibitors",
            "Loop diuretics",
            "SGLT2 inhibitors"
        ],
        "options": [
            "Osmotic agents",
            "Potassium-sparing diuretics",
            "Thiazides",
            "Carbonic anhydrase inhibitors",
            "Loop diuretics",
            "SGLT2 inhibitors"
        ],
        "question": "What are the names of different classes of diuretics mentioned?",
        "source": {
            "isbn": "978-1260117127",
            "page": 152,
            "paragraph_id": "978-1260117127-p152-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Zileuton",
            "Corticosteroids",
            "Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)"
        ],
        "options": [
            "Phosphodiesterase inhibitors",
            "Cyclosporine",
            "Corticosteroids",
            "Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)",
            "Prostaglandin Synthesis Inhibitors",
            "HMG-CoA Reductase Inhibitors",
            "Angiotensin-Converting Enzyme (ACE) Inhibitors",
            "Beta Blockers",
            "Zileuton",
            "Statins",
            "Calcium Channel Blockers",
            "Thrombopoietin Receptor Agonists",
            "Glucocorticoid receptor agonists"
        ],
        "question": "What types of drugs inhibit phospholipase A2 or cyclooxygenase enzymes according to their primary action?",
        "source": {
            "isbn": "978-1260117127",
            "page": 174,
            "paragraph_id": "978-1260117127-p174-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sumatriptan"
        ],
        "options": [
            "Phentermine",
            "Orlistat",
            "Fenfluramine",
            "Sumatriptan",
            "Naltrexone",
            "Liraglutide",
            "Ergotamine",
            "Nitroprusside",
            "Ranitidine",
            "Ondansetron",
            "Diphenhydramine"
        ],
        "question": "What medications are classified under triptans?",
        "source": {
            "isbn": "978-1260117127",
            "page": 163,
            "paragraph_id": "978-1260117127-p163-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Captopril",
            "Enalapril"
        ],
        "options": [
            "Aliskiren",
            "Losartan",
            "Captopril",
            "Enalapril",
            "Bosentan",
            "Ecallantide",
            "Sacubitril"
        ],
        "question": "What are the names of ACE inhibitors mentioned?",
        "source": {
            "isbn": "978-1260117127",
            "page": 170,
            "paragraph_id": "978-1260117127-p170-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Felbamate",
            "Gabapentin",
            "Lacosamide",
            "Perampanel",
            "Phenobarbital",
            "Retigabine",
            "Rufinamide",
            "Tagabine",
            "Topiramate",
            "Vigabatin",
            "Zonisamide"
        ],
        "options": [
            "Carbamazepine",
            "Felbamate",
            "Gabapentin",
            "Lacosamide",
            "Lamotrigine",
            "Levetiracetam",
            "Perampanel",
            "Phenobarbital",
            "Retigabine",
            "Rufinamide",
            "Tagabine",
            "Topiramate",
            "Vigabatin",
            "Zonisamide",
            "Ethosuximide",
            "Phenytoin",
            "Valproate"
        ],
        "question": "What are the names of medications listed under \"Back-up & adjunctive drugs\" for treating epilepsy?",
        "source": {
            "isbn": "978-1260117127",
            "page": 215,
            "paragraph_id": "978-1260117127-p215-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Beta agonists",
            "Muscarinic antagonists",
            "Methylxanthines"
        ],
        "options": [
            "Beta agonists",
            "Muscarinic antagonists",
            "Methylxanthines",
            "Corticosteroids",
            "Mast cell stabilizers"
        ],
        "question": "What types of bronchodilators are listed for treating conditions related to respiratory diseases?",
        "source": {
            "isbn": "978-1260117127",
            "page": 183,
            "paragraph_id": "978-1260117127-p183-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Carbamazepine",
            "Phenytoin",
            "Valproate",
            "Lamotrigine",
            "Levetiracetam",
            "Topiramate",
            "Gabapentin",
            "Zonisamide"
        ],
        "options": [
            "Carbamazepine",
            "Phenytoin",
            "Valproate",
            "Lamotrigine",
            "Levetiracetam",
            "Topiramate",
            "Gabapentin",
            "Zonisamide",
            "Clonazepam",
            "Ethosuximide",
            "Pregabalin"
        ],
        "question": "What antiseizure drugs are commonly used for treating generalized tonic-clonic seizures?",
        "source": {
            "isbn": "978-1260117127",
            "page": 221,
            "paragraph_id": "978-1260117127-p221-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Nitric oxide gas",
            "Nitroglycerin",
            "Other nitrates",
            "Nitroprusside"
        ],
        "options": [
            "Acetylcholine",
            "Histamine",
            "Nitric oxide gas",
            "Riociguat",
            "Nitrogen dioxide"
        ],
        "question": "What substances activate guanylyl cyclase by releasing nitric oxide?",
        "source": {
            "isbn": "978-1260117127",
            "page": 182,
            "paragraph_id": "978-1260117127-p182-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Acute anxiety states",
            "Panic attacks"
        ],
        "options": [
            "Acute anxiety states",
            "Chronic anxiety states",
            "Panic attacks",
            "Bipolar disorder",
            "Muscle spasticity",
            "Seizure disorders"
        ],
        "question": "What types of conditions do benzodiazepines favorably treat?",
        "source": {
            "isbn": "978-1260117127",
            "page": 203,
            "paragraph_id": "978-1260117127-p203-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Mental retardation",
            "Abnormalities of the head and face",
            "Growth deficiency"
        ],
        "options": [
            "Increased susceptibility to bacterial pneumonia",
            "Cardiac arrhythmias",
            "Abnormalities of the head and face",
            "Ocular dysfunction",
            "Growth deficiency",
            "Horizontal nystagmus"
        ],
        "question": "What conditions or characteristics are included in the definition of Fetal Alcohol Syndrome?",
        "source": {
            "isbn": "978-1260117127",
            "page": 212,
            "paragraph_id": "978-1260117127-p212-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Receptors that modify gene transcription: steroid hormones",
            "Receptors on membrane-spanning enzymes: insulin-like growth factor",
            "Receptors activating Janus kinases: interferons",
            "Receptors directly coupled to ion channels: ligand-gated ion channels",
            "Receptors coupled to enzymes via G-proteins: adenosine, dopamine, epinephrine",
            "Receptors that are enzymes themselves: tyrosine kinase receptors"
        ],
        "options": [
            "Ionotropic receptors",
            "Metabotropic receptors",
            "Enzyme-linked receptors",
            "Hormone-sensitive lipase receptors",
            "Steroid hormone receptors"
        ],
        "question": "What kinds of receptors can modify biological processes?",
        "source": {
            "isbn": "978-1260117127",
            "page": 230,
            "paragraph_id": "978-1260117127-p230-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Tiagabine",
            "Topiramate",
            "Zonisamide",
            "Lamotrigine"
        ],
        "options": [
            "Tiagabine",
            "Topiramate",
            "Zonisamide",
            "Lamotrigine",
            "Carbamazepine"
        ],
        "question": "What antiseizure medications are listed along with their mechanisms of action and clinical applications?",
        "source": {
            "isbn": "978-1260117127",
            "page": 223,
            "paragraph_id": "978-1260117127-p223-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Quetiapine",
            "Olanzapine"
        ],
        "options": [
            "Lithium",
            "Quetiapine",
            "Olanzapine",
            "Thioridazine",
            "Clozapine",
            "Haloperidol",
            "Valproate",
            "Carbamazepine",
            "Ziprasidone",
            "Chlorpromazine"
        ],
        "question": "Which medications are considered alternatives for treating bipolar disorder?",
        "source": {
            "isbn": "978-1260117127",
            "page": 260,
            "paragraph_id": "978-1260117127-p260-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Parkinsonism",
            "Choreoathetosis",
            "is not present; instead we find:",
            "Athetosis",
            "Chorea",
            "Dyskinesia",
            "Dystonia",
            "Tics",
            "Tremor"
        ],
        "options": [
            "Parkinsonism",
            "Chorea",
            "Dyskinesia",
            "Athetosis",
            "Tics",
            "Myasthenia gravis",
            "Hypertension",
            "Hyperthyroidism"
        ],
        "question": "What types of movement disorders are included among the various neurologic conditions?",
        "source": {
            "isbn": "978-1260117127",
            "page": 245,
            "paragraph_id": "978-1260117127-p245-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Neuromuscular blocking agents",
            "Centrally acting muscle relaxants"
        ],
        "options": [
            "Nonsteroidal anti-inflammatory drugs",
            "Anticonvulsants",
            "Neuromuscular blocking agents",
            "Centrally acting muscle relaxants"
        ],
        "question": "What categories of skeletal muscle relaxants exist?",
        "source": {
            "isbn": "978-1260117127",
            "page": 237,
            "paragraph_id": "978-1260117127-p237-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Pramipexole",
            "Ropinirole",
            "Apomorphine",
            "Rotigotine",
            "Bromocriptine"
        ],
        "options": [
            "Levodopa",
            "Pramipexole",
            "Bromocriptine",
            "Entacapone",
            "Apomorphine",
            "Tolcapone",
            "Benztropine"
        ],
        "question": "What medications are listed under Dopamine agonists?",
        "source": {
            "isbn": "978-1260117127",
            "page": 252,
            "paragraph_id": "978-1260117127-p252-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Anxiety disorders",
            "Chronic pain management",
            "Migraine prophylaxis",
            "Smoking cessation",
            "Obesity treatment",
            "Attention Deficit Hyperactivity Disorder (ADHD)"
        ],
        "options": [
            "Anxiety disorders",
            "Chronic pain management",
            "Attention Deficit Hyperactivity Disorder (ADHD)",
            "Obesity treatment",
            "Smoking cessation",
            "Migraine prophylaxis",
            "Hypertension management"
        ],
        "question": "What are the different uses of antidepressant medications?",
        "source": {
            "isbn": "978-1260117127",
            "page": 265,
            "paragraph_id": "978-1260117127-p265-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Tricyclic antidepressants"
        ],
        "options": [
            "Tricyclic antidepressants",
            "Selective serotonin reuptake inhibitors (SSRIs)",
            "Serotonin-norepinephrine reuptake inhibitors (SNRIs)",
            "Monoamine oxidase inhibitors (MAOIs)"
        ],
        "question": "Which subclasses of antidepressant medications can cause significant anticholinergic side effects?",
        "source": {
            "isbn": "978-1260117127",
            "page": 269,
            "paragraph_id": "978-1260117127-p269-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Methadone",
            "Other strong \u00b5-receptor agonists"
        ],
        "options": [
            "Buprenorphine",
            "Codeine",
            "Methadone",
            "Nalbuphine",
            "Naloxone",
            "Naltrexone",
            "Tramadol",
            "Oxycodone",
            "Hydrocodone",
            "Morphine"
        ],
        "question": "What are the names of the opioid analgesics that can alleviate symptoms experienced by patients physically dependent on an opioid agonist?",
        "source": {
            "isbn": "978-1260117127",
            "page": 276,
            "paragraph_id": "978-1260117127-p276-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Full agonists",
            "Partial agonists",
            "Mixed agonist-antagonists",
            "Antagonists"
        ],
        "options": [
            "Full agonists",
            "Mixed agonist-antagonists",
            "Pure antagonists",
            "Nonopioid medications",
            "Partial agonists"
        ],
        "question": "What subclasses of opioids are described along with their mechanisms of action?",
        "source": {
            "isbn": "978-1260117127",
            "page": 278,
            "paragraph_id": "978-1260117127-p278-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Heparin",
            "Direct thrombin inhibitors",
            "Direct factor X inhibitors",
            "Orally active coumarin derivatives"
        ],
        "options": [
            "Antipyretics",
            "Analgesics",
            "Anesthetics",
            "Anti-inflammatory",
            "Antihistamines",
            "Heparin",
            "Direct thrombin inhibitors",
            "Factor X inhibitors",
            "Orally active coumarin derivatives"
        ],
        "question": "What types of anticoagulants are discussed?",
        "source": {
            "isbn": "978-1260117127",
            "page": 296,
            "paragraph_id": "978-1260117127-p296-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sedatives/Hypnotics",
            "Cannabinoids",
            "Stimulant Compounds",
            "Opioids"
        ],
        "options": [
            "Sedatives/Hypnotics",
            "Cannabinoids",
            "Stimulant Compounds",
            "Antidepressants",
            "Anesthetics"
        ],
        "question": "What types of psychoactive drugs exhibit significant dependency and addiction liabilities?",
        "source": {
            "isbn": "978-1260117127",
            "page": 285,
            "paragraph_id": "978-1260117127-p285-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Alteplase",
            "Reteplase",
            "Tenecteplase",
            "Streptokinase"
        ],
        "options": [
            "Alteplase",
            "Rivaroxaban",
            "Clabigatran",
            "Streptokinase",
            "Reteplase",
            "Tenecteplase"
        ],
        "question": "What types of thrombolytic drugs are commonly used?",
        "source": {
            "isbn": "978-1260117127",
            "page": 300,
            "paragraph_id": "978-1260117127-p300-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Glycoprotein IIb/IIIa inhibitors",
            "ADP receptor antagonists",
            "PDE and adenosine uptake inhibitors",
            "Protease-activated receptor-1 (PAR-1) antagonists"
        ],
        "options": [
            "Glycoprotein IIb/IIIa inhibitors",
            "ADP receptor antagonists",
            "PDE and adenosine uptake inhibitors",
            "Protease-activated receptor-1 (PAR-1) antagonists",
            "Anti-plasmin drugs"
        ],
        "question": "What types of medications can inhibit platelet aggregation?",
        "source": {
            "isbn": "978-1260117127",
            "page": 307,
            "paragraph_id": "978-1260117127-p307-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
            "Acetaminophen",
            "Disease-modifying antirheumatic drugs (DMARDs)",
            "Uricosurics",
            "Allopurinol",
            "Febuxostat"
        ],
        "options": [
            "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
            "Acetaminophen",
            "Disease-modifying antirheumatic drugs (DMARDs)",
            "Uricosurics",
            "Allopurinol",
            "Febuxostat"
        ],
        "question": "What types of medications are commonly used for treating conditions related to inflammation?",
        "source": {
            "isbn": "978-1260117127",
            "page": 317,
            "paragraph_id": "978-1260117127-p317-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Microcytic anemia caused by iron deficiency",
            "Megaloblastic anemia caused by folic acid deficiency"
        ],
        "options": [
            "Microcytic anemia caused by iron deficiency",
            "Megaloblastic anemia caused by folic acid deficiency",
            "Normocytic anemia caused by lack of vitamins",
            "Pernicious anemia caused by cobalamin deficiency",
            "Macrocytic anemia"
        ],
        "question": "What types of anemias can result from deficiencies of certain nutrients?",
        "source": {
            "isbn": "978-1260117127",
            "page": 293,
            "paragraph_id": "978-1260117127-p293-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Allopurinol",
            "Febuxostat"
        ],
        "options": [
            "Allopurinol",
            "Febuxostat",
            "Pegloticase",
            "Urkase"
        ],
        "question": "What medications fall under the category of Xanthine Oxidase Inhibitors for treating conditions related to excess uric acid production?",
        "source": {
            "isbn": "978-1260117127",
            "page": 327,
            "paragraph_id": "978-1260117127-p327-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Etanercept",
            "Infliximab",
            "Rituximab",
            "Abatacept",
            "Tocilizumab",
            "Baricitinib"
        ],
        "options": [
            "Hydroxychloroquine",
            "Sulfasalazine",
            "Leflunomide",
            "Etanercept",
            "Methotrexate",
            "Infliximab",
            "Rituximab",
            "Abatacept",
            "Tocilizumab",
            "Baricitinib"
        ],
        "question": "What medications are classified under DMARDs and which ones specifically block TNF-alpha?",
        "source": {
            "isbn": "978-1260117127",
            "page": 325,
            "paragraph_id": "978-1260117127-p325-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Growth hormone receptor antagonists: Pegvisomant",
            "Gonadotropins:",
            "FSH analogs: Follitropin alpha, Follitropin beta, Urofollitropin, Menotropins",
            "LH analogs: Human chorionic gonadotropin (hCG), Choriogonadotropin alfa, Lutropin, Menotropins",
            "GnRH analogs: Leuprolide, Gonadorelin, Goserelin, Buserelin, Histrelin, Nafarelin, Triptorelin",
            "GnRH receptor antagonists: Ganirelix, Cetrorelix, Degarelix, Abarelix",
            "Dopamine agonists: Bromocriptine, Cabergoline"
        ],
        "options": [
            "Growth hormone receptor antagonists: Pegvisomant",
            "Gonadotropins:",
            "FSH analogs: Follitropin alpha, Follitropin beta, Urofollitropin, Menotropins",
            "LH analogs: Human chorionic gonadotropin (hCG), Choriogonadotropin alfa, Lutropin, Menotropins",
            "GnRH analogs: Leuprolide, Gonadorelin, Goserelin, Buserelin, Histrelin, Nafarelin, Triptorelin",
            "GnRH receptor antagonists: Ganirelix, Cetrorelix, Degarelix, Abarelix",
            "Dopamine agonists: Bromocriptine, Cabergoline"
        ],
        "question": "What are the different types of hormones/drugs and their specific examples mentioned for treating various conditions related to hormonal imbalances?",
        "source": {
            "isbn": "978-1260117127",
            "page": 336,
            "paragraph_id": "978-1260117127-p336-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sa-Reductase",
            "Anabolic steroid",
            "Breakthrough bleeding",
            "Combined oral contraceptive",
            "Androgen receptor agonist",
            "SERM",
            "Estradiol",
            "Diethylstilbestrol",
            "Progestin",
            "Progesterone",
            "Gonadotropins"
        ],
        "options": [
            "Sa-Reductase",
            "Anabolic steroid",
            "Breakthrough bleeding",
            "Combined oral contraceptive",
            "Androgen receptor agonist",
            "Vaginal bleeding",
            "SERM",
            "Estradiol",
            "Conjugated estrogens",
            "Diethylstilbestrol",
            "Progestin",
            "Progesterone",
            "Norethindrone",
            "Gonadotropins",
            "Desogestrel",
            "Mestranol",
            "Ethinyl estradiol"
        ],
        "question": "What types of hormones or related terms are specifically defined within the given medical context?",
        "source": {
            "isbn": "978-1260117127",
            "page": 352,
            "paragraph_id": "978-1260117127-p352-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Parathyroid hormone (PTH)",
            "Estrogen",
            "Calcitonin"
        ],
        "options": [
            "Parathyroid hormone (PTH)",
            "Estrogen",
            "Insulin",
            "Thyroxine",
            "Glucagon"
        ],
        "question": "What are the primary hormones involved in maintaining bone health?",
        "source": {
            "isbn": "978-1260117127",
            "page": 374,
            "paragraph_id": "978-1260117127-p374-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Relieving severe hypoglycemia in diabetics",
            "Management of severe p-blocker overdose"
        ],
        "options": [
            "Treating mild cases of hypoglycemia",
            "Managing severe beta-blocker overdose",
            "Relaxing smooth muscles throughout the body",
            "Increasing heart rate and contraction force",
            "Reducing hepatic glycogenolysis and gluconeogenesis",
            "Administering during meals to delay carbohydrate absorption",
            "Used to manage severe ketoacidosis",
            "Lowering blood pH levels"
        ],
        "question": "What are the primary clinical uses of glucagon?",
        "source": {
            "isbn": "978-1260117127",
            "page": 368,
            "paragraph_id": "978-1260117127-p368-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Cortisol",
            "Prednisone",
            "Triamcinolone",
            "Dexamethasone",
            "Aldosterone",
            "Fludrocortisone"
        ],
        "options": [
            "Cortisol",
            "Prednisone",
            "Triamcinolone",
            "Dexamethasone",
            "Aldosterone",
            "Fludrocortisone"
        ],
        "question": "What hormones are classified under glucocorticoids and mineralocorticoids?",
        "source": {
            "isbn": "978-1260117127",
            "page": 346,
            "paragraph_id": "978-1260117127-p346-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Alendronate",
            "Risedronate",
            "Ibandronate",
            "Pamidronate",
            "Zoledronate"
        ],
        "options": [
            "Alendronate",
            "Teriparatide",
            "Calcitriol",
            "Denosumab",
            "Paricalcitol",
            "Ibandronate"
        ],
        "question": "What are the drugs classified under Bisphosphonates?",
        "source": {
            "isbn": "978-1260117127",
            "page": 379,
            "paragraph_id": "978-1260117127-p379-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "B. Sa-Reductase Inhibitors",
            "C. Gonadotropln-Releasing Hormone Analogs and Antagonists",
            "E. Inhibitors of Steroid Synthesis"
        ],
        "options": [
            "B. Sa-Reductase Inhibitors",
            "C. Gonadotropln-Releasing Hormone Analogs and Antagonists",
            "E. Inhibitors of Steroid Synthesis",
            "Anti-androgen Receptor Blockers",
            "Progestins"
        ],
        "question": "What types of inhibitors or classes of medications are described as affecting androgen activity?",
        "source": {
            "isbn": "978-1260117127",
            "page": 357,
            "paragraph_id": "978-1260117127-p357-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Both gram-positive and gram-negative bacteria, along with anaerobes"
        ],
        "options": [
            "Gram-positive bacteria only",
            "Gram-negative bacteria only",
            "Anaerobic bacteria only",
            "Both gram-positive and gram-negative bacteria, along with anaerobes"
        ],
        "question": "What types of bacteria can tetracyclines effectively target?",
        "source": {
            "isbn": "978-1260117127",
            "page": 398,
            "paragraph_id": "978-1260117127-p398-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Both aerobic and anaerobic gram-positive bacteria"
        ],
        "options": [
            "Anaerobic gram-positive bacteria",
            "Aerobic gram-negative bacteria",
            "Both aerobic and anaerobic gram-positive bacteria",
            "Only streptococci"
        ],
        "question": "What types of bacteria do fidaxomicin target?",
        "source": {
            "isbn": "978-1260117127",
            "page": 394,
            "paragraph_id": "978-1260117127-p394-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Certain gram-negative rods including Klebsiella, Pseudimonas, and Serratia"
        ],
        "options": [
            "Gram-positive bacteria",
            "Anaerobic bacteria",
            "Certain gram-negative rods including Klebsiella, Pseudomonas, and Serratia",
            "Aminoglycoside-producing bacteria",
            "Staphylococcus aureus",
            "Bacillus subtilis"
        ],
        "question": "What types of bacteria does aztreonam exhibit resistance towards due to being affected by their beta-lactamases?",
        "source": {
            "isbn": "978-1260117127",
            "page": 385,
            "paragraph_id": "978-1260117127-p385-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ulcerative Colitis",
            "Nocardiosis",
            "Toxoplasmosis",
            "Pneumocystis pneumonia"
        ],
        "options": [
            "Ulcerative Colitis",
            "Nocardiosis",
            "Toxoplasmosis",
            "Urinary Tract Infections",
            "Otitis Media",
            "Rheumatoid Arthritis",
            "Gonorrhea",
            "Chlamydial Urethritis",
            "Diarrheal diseases caused by bacteria",
            "Respiratory Tract Infection",
            "Skin Rash Hypersensitivity Reaction"
        ],
        "question": "What are the names of the conditions for which the drug combinations involving sulfadiazine and trimethoprim-sulfamethoxazole are effective?",
        "source": {
            "isbn": "978-1260117127",
            "page": 408,
            "paragraph_id": "978-1260117127-p408-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sulfadiazine",
            "Sulfaquinoxaline",
            "Trimethoprim-sulfamethoxazole"
        ],
        "options": [
            "Penicillin",
            "Tetracycline",
            "Sulfadiazine",
            "Sulfaquinoxaline",
            "Trimethoprim"
        ],
        "question": "What are some common types of sulfonamide drugs?",
        "source": {
            "isbn": "978-1260117127",
            "page": 410,
            "paragraph_id": "978-1260117127-p410-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ketoconazole",
            "Fluconazole",
            "Itraconazole",
            "Voriconazole",
            "Posaconazole",
            "Isavuconazole"
        ],
        "options": [
            "Itraconazole",
            "Ketoconazole",
            "Fluconazole",
            "Voriconazole",
            "Posaconazole",
            "Isavuconazole"
        ],
        "question": "What are the names of the triazoles discussed regarding their clinical uses?",
        "source": {
            "isbn": "978-1260117127",
            "page": 420,
            "paragraph_id": "978-1260117127-p420-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Nucleoside reverse transcriptase inhibitors",
            "Inhibitors of HIV protease"
        ],
        "options": [
            "Protease inhibitors alone",
            "Non-nucleoside reverse transcriptase inhibitors alone",
            "Fusion inhibitors alone",
            "CCR-5 antagonists alone",
            "A combination of nucleoside reverse transcriptase inhibitors and protease inhibitors"
        ],
        "question": "What types of inhibitors are commonly included in highly active antiretroviral therapy (HAART) for treating HIV?",
        "source": {
            "isbn": "978-1260117127",
            "page": 428,
            "paragraph_id": "978-1260117127-p428-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Atazanavir",
            "Lamivudine"
        ],
        "options": [
            "Didanosine",
            "Stavudine",
            "Atazanavir",
            "Lamivudine",
            "Ribavirin"
        ],
        "question": "What medications are considered replacements when treating symptomatic AIDS patients who require discontinuation of certain drugs?",
        "source": {
            "isbn": "978-1260117127",
            "page": 434,
            "paragraph_id": "978-1260117127-p434-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Imidazoles",
            "Polypeptides",
            "Oxidizing agents",
            "Acids",
            "Heavy metals",
            "Chlorinated phenols"
        ],
        "options": [
            "Imidazoles",
            "Polypeptides",
            "Oxidizing agents",
            "Acids",
            "Heavy metals",
            "Chlorinated phenols"
        ],
        "question": "What types of chemical compounds are listed among the miscellaneous antimicrobial agents?",
        "source": {
            "isbn": "978-1260117127",
            "page": 438,
            "paragraph_id": "978-1260117127-p438-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Nausea",
            "Dizziness",
            "Fatigue",
            "Increase in creatine kinase with potential for myopathy or rhabdomyolysis"
        ],
        "options": [
            "Nausea",
            "Fatigue",
            "Myocarditis",
            "Gastrointestinal upset",
            "Hypertension",
            "Headache",
            "Increase in creatine kinase leading to myopathy or rhabdomyolysis"
        ],
        "question": "What adverse effects are specifically noted for Raltegravir?",
        "source": {
            "isbn": "978-1260117127",
            "page": 431,
            "paragraph_id": "978-1260117127-p431-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "None listed specifically for treating schistosome-related conditions; however, the following are general treatments discussed:",
            "No explicit mention of any option being effective against schistosomes in the given text snippet; instead, discuss treatments for various parasitic infections generally.",
            "Note: Treatments targeting blood flukes aren't specified among options A through E, suggesting a gap between query specifics and available data within provided excerpts regarding their efficacy towards certain kinds organisms like *Schistosoma* spp., where indeed metrifonate & oxamniquine are considered rather than choices presented here which relate broadly across different parasite classes rather than exclusively upon Trematoda class members."
        ],
        "options": [
            "Ivermectin",
            "Moxidectin",
            "Mebendazole",
            "Primaquine",
            "Metronidazole"
        ],
        "question": "What types of antiparasitic medications target schistosomes?",
        "source": {
            "isbn": "978-1260117127",
            "page": 461,
            "paragraph_id": "978-1260117127-p461-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Enterobacter",
            "Pseudomonas aeruginosa"
        ],
        "options": [
            "Listeria monocytogenes",
            "Bacillus subtilis",
            "Enterobacter",
            "Escherichia coli",
            "Corynebacterium diphtheriae",
            "Pseudomonas aeruginosa"
        ],
        "question": "What types of bacteria have inducible beta-lactamases?",
        "source": {
            "isbn": "978-1260117127",
            "page": 449,
            "paragraph_id": "978-1260117127-p449-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Susceptibility testing",
            "Drug concentration in blood",
            "Serum bactericidal titers",
            "Route of administration",
            "Monitoring of therapeutic response"
        ],
        "options": [
            "Determination of the causative agent's identity",
            "Selection of the least expensive antibiotic option available",
            "Measurement of drug concentration in tissues other than blood",
            "Disk diffusion method for susceptibility testing",
            "Monitoring of therapeutic response",
            "Estimation of serum bactericidal titers"
        ],
        "question": "What principles guide antimicrobial therapy in established infections?",
        "source": {
            "isbn": "978-1260117127",
            "page": 444,
            "paragraph_id": "978-1260117127-p444-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Metronidazole",
            "Tinidazole"
        ],
        "options": [
            "Metronidazole",
            "Tinidazole",
            "Diloxanide",
            "Iodoquinol",
            "Paromomycin"
        ],
        "question": "What drugs are classified under Antiamebic agents?",
        "source": {
            "isbn": "978-1260117127",
            "page": 458,
            "paragraph_id": "978-1260117127-p458-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Choriocarcinoma",
            "Acute leukemias",
            "Non-Hodgkin and primary central nervous system lymphomas",
            "Breast cancer",
            "Head and neck cancer",
            "Bladder cancer"
        ],
        "options": [
            "Acute myeloid leukemia",
            "Choriocarcinoma",
            "Non-small-cell lung cancer",
            "Breast cancer",
            "Chronic lymphocytic leukemia",
            "Head and neck cancer",
            "Bladder cancer",
            "Ovarian cancer"
        ],
        "question": "What types of cancers does methotrexate effectively treat?",
        "source": {
            "isbn": "978-1260117127",
            "page": 469,
            "paragraph_id": "978-1260117127-p469-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Immunopoteniators",
            "Immunosuppressants"
        ],
        "options": [
            "Immunopoteniators",
            "Immunosuppressants",
            "Antibiotics",
            "Anti-inflammatory drugs"
        ],
        "question": "What are the primary classifications of drugs involved in modulating immune functions?",
        "source": {
            "isbn": "978-1260117127",
            "page": 477,
            "paragraph_id": "978-1260117127-p477-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Erythropoietin",
            "Filgrastim (G-CSF)",
            "Sargramostim (GM-CSF)",
            "Oprelvekin (IL-11)"
        ],
        "options": [
            "Filgrastim (G-CSF)",
            "Sargramostim (GM-CSF)",
            "Oprelvekin (IL-11)",
            "Cyclophosphamide",
            "Bleomycin"
        ],
        "question": "What are the names of the agents provided by recombinant DNA technology to manage hematotoxicity?",
        "source": {
            "isbn": "978-1260117127",
            "page": 474,
            "paragraph_id": "978-1260117127-p474-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Pollutants",
            "Agricultural chemicals",
            "Solvents",
            "Pesticides",
            "PCBs",
            "Dioxins",
            "Chlorinated hydrocarbons",
            "Asbestos",
            "Cholinesterase inhibitors",
            "Metals",
            "Botanical",
            "Herbicides",
            "Halogenated aliphatic hydrocarbons",
            "Aromatic hydrocarbons",
            "Glyphosate",
            "Bipyridyl compounds"
        ],
        "options": [
            "Metals",
            "Botanical",
            "Herbicides",
            "Cholinesterase inhibitors",
            "Asbestos",
            "Sulfur oxides",
            "Hydrocarbons",
            "Particulate matter",
            "Nitrogen oxides"
        ],
        "question": "What types of substances contribute to environmental toxicity?",
        "source": {
            "isbn": "978-1260117127",
            "page": 491,
            "paragraph_id": "978-1260117127-p491-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Eye irritation",
            "Skin irritation"
        ],
        "options": [
            "Eye irritation",
            "Skin irritation",
            "Muscle hypotonia",
            "Non-Hodgkin lymphoma",
            "Gastrointestinal irritation",
            "Bloody stools",
            "Hematemesis",
            "Severe pulmonary fibrosis"
        ],
        "question": "What are the health issues caused by glyphosate exposure?",
        "source": {
            "isbn": "978-1260117127",
            "page": 494,
            "paragraph_id": "978-1260117127-p494-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Arsenic",
            "Inorganic arsenic",
            "Iron",
            "Lead",
            "Methylmercury",
            "Tetraethyl lead"
        ],
        "options": [
            "Acetaminophen",
            "Arsenic",
            "Deferoxamine",
            "Hemoglobin",
            "Hydrogen Peroxide",
            "Inorganic arsenic",
            "Iron",
            "Lead",
            "Methemoglobin",
            "Methylmercury",
            "Penicillamine",
            "Tetraethyl lead",
            "Transferrin",
            "Vitamin C"
        ],
        "question": "What substances might cause distinct health issues when they come into contact with humans?",
        "source": {
            "isbn": "978-1260117127",
            "page": 501,
            "paragraph_id": "978-1260117127-p501-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Cyanide",
            "Ethanol",
            "Ethylene glycol",
            "Ibuprofen",
            "Isoniazid",
            "Iron",
            "Methanol",
            "Phenelzine",
            "Salicylates",
            "Tranylcypromine",
            "Valproic acid",
            "Verapamil"
        ],
        "options": [
            "Ethanol",
            "Methanol",
            "Ibuprofen",
            "Salicylates",
            "Digitalis",
            "Naloxone",
            "Barium"
        ],
        "question": "What substances can cause an increased anion gap?",
        "source": {
            "isbn": "978-1260117127",
            "page": 504,
            "paragraph_id": "978-1260117127-p504-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Anticholinergics",
            "Anti-TNF drugs",
            "Proton pump inhibitors",
            "Cholinomimetics",
            "Serotonin antagonists",
            "Immunosuppressants",
            "Laxatives"
        ],
        "options": [
            "Anticholinergics",
            "Anti-TNF drugs",
            "Proton pump inhibitors",
            "Cholinomimetics",
            "Metabolism promoters",
            "Serotonin antagonists",
            "Immunosuppressants",
            "Laxatives"
        ],
        "question": "What types of drugs are specifically used for treating gastrointestinal disorders?",
        "source": {
            "isbn": "978-1260117127",
            "page": 511,
            "paragraph_id": "978-1260117127-p511-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Steatorrhea resulting from decreased fat absorption"
        ],
        "options": [
            "Steatorrhea resulting from decreased fat absorption",
            "Diabetic gastroparesis",
            "Portal hypertension leading to variceal hemorrhage",
            "Cholesterol gallstone formation",
            "Chemotherapy-induced nausea and vomiting"
        ],
        "question": "What conditions occur when there is inadequate pancreatic secretion of certain enzymes?",
        "source": {
            "isbn": "978-1260117127",
            "page": 516,
            "paragraph_id": "978-1260117127-p516-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Reduction of cholesterol secretion into bile",
            "Treatment of gallstones in patients refusing or not eligible for surgery"
        ],
        "options": [
            "Variceal bleeding",
            "Treatment of hypertension",
            "Reduction of cholesterol secretion into bile",
            "Hyperglycemia management",
            "Pancreatic insufficiency treatment",
            "Treatment of gout",
            "GERD treatment"
        ],
        "question": "What are the clinical applications of Ursodiol?",
        "source": {
            "isbn": "978-1260117127",
            "page": 520,
            "paragraph_id": "978-1260117127-p520-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Additive effects",
            "Antagonism",
            "Pharmacodynamic interadion",
            "Pharmacokinetic lnteraction",
            "Synergism"
        ],
        "options": [
            "Additive effects",
            "Antagonism",
            "Pharmacodynamic interadion",
            "Pharmacokinetic lnteraction",
            "Synergism"
        ],
        "question": "What types of drug interaction effects can occur when two drugs are administered simultaneously?",
        "source": {
            "isbn": "978-1260117127",
            "page": 530,
            "paragraph_id": "978-1260117127-p530-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ginseng"
        ],
        "options": [
            "Ginseng",
            "Milk Thistle",
            "St. John's Wort",
            "Saw Palmetto",
            "Coenzyme Q10"
        ],
        "question": "What herbal supplements discussed have estrogenic side effects?",
        "source": {
            "isbn": "978-1260117127",
            "page": 526,
            "paragraph_id": "978-1260117127-p526-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Indomethacin",
            "Ketorolac"
        ],
        "options": [
            "Indomethacin",
            "Interferon-alpha",
            "Lamivudine",
            "Ketoconazole",
            "Ketorolac"
        ],
        "question": "What medications belong to the class of drugs primarily associated with treating conditions through inhibition of prostaglandin synthesis?",
        "source": {
            "isbn": "978-1260117127",
            "page": 545,
            "paragraph_id": "978-1260117127-p545-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Alpha-adrenergic receptors"
        ],
        "options": [
            "Beta adrenergic receptors",
            "Histamine receptors",
            "Serotonin receptors",
            "Vasopressin receptors",
            "Alpha-adrenergic receptors"
        ],
        "question": "What types of receptors does a medication used to treat anaphylaxis act upon to produce a significant vasoconstrictor effect?",
        "source": {
            "isbn": "978-1260117127",
            "page": 569,
            "paragraph_id": "978-1260117127-p569-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sympathomimetics",
            "Loop diuretics",
            "\u03b1 agonists",
            "Calcium channel blockers"
        ],
        "options": [
            "Sympathomimetics",
            "Ganglion blockers",
            "Pheochromocytoma treatments",
            "Loop diuretics",
            "Calcium channel blockers"
        ],
        "question": "What types of medications can affect blood pressure?",
        "source": {
            "isbn": "978-1260117127",
            "page": 587,
            "paragraph_id": "978-1260117127-p587-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Group 1 (sodium channel blockers)",
            "Group 2 (~ blockers)",
            "Group 3 (potassium channel blockers)",
            "Group 4 (calcium channel blockers)"
        ],
        "options": [
            "Group 0",
            "Group 1 (sodium channel blockers)",
            "Group 2 (~ blockers)",
            "Group 3 (potassium channel blockers)",
            "Group 4 (calcium channel blockers)"
        ],
        "question": "What types of antiarrhythmic drugs exist according to their classification?",
        "source": {
            "isbn": "978-1260117127",
            "page": 585,
            "paragraph_id": "978-1260117127-p585-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Corticosteroid-binding globulin (CBG)",
            "Glucocorticoids",
            "Corticosteroid antagonists"
        ],
        "options": [
            "Corticosteroid-binding globulin (CBG)",
            "Glucocorticoids",
            "Corticosteroid antagonists",
            "Catechol-O-methyltransferase (COMT) inhibitors"
        ],
        "question": "What types of corticosteroids-related substances are discussed?",
        "source": {
            "isbn": "978-1260117127",
            "page": 590,
            "paragraph_id": "978-1260117127-p590-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Familial Hypertriglyceridemia"
        ],
        "options": [
            "Type I Hyperlipoproteinemia",
            "Familial Combined Hyperlipoproteinemia",
            "Familial Hypercholesterolemia",
            "Familial Hypertriglyceridemia",
            "Other forms of dyslipidemia"
        ],
        "question": "What types of hyperlipoproteinemias are listed?",
        "source": {
            "isbn": "978-1260117127",
            "page": 596,
            "paragraph_id": "978-1260117127-p596-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Phosphate",
            "Phosphodiesterase (PDE)",
            "Phosphodiesterase (PDE) inhibitors",
            "Phospholipase A2"
        ],
        "options": [
            "Phosphate",
            "Phosphodiesterase (PDE)",
            "Phosphodiesterase (PDE) inhibitors",
            "Phospholipase A2"
        ],
        "question": "What types of phosphorus-containing compounds are mentioned?",
        "source": {
            "isbn": "978-1260117127",
            "page": 604,
            "paragraph_id": "978-1260117127-p604-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Type I (immediate) drug allergy",
            "Type II drug allergy",
            "Type III drug allergy",
            "Type IV drug allergy"
        ],
        "options": [
            "Type 0 drug allergy",
            "Type I (immediate) drug allergy",
            "Type II drug allergy",
            "Type III drug allergy",
            "Type IV drug allergy"
        ],
        "question": "What types of allergies related to medications can occur?",
        "source": {
            "isbn": "978-1260117127",
            "page": 609,
            "paragraph_id": "978-1260117127-p609-para1"
        },
        "type": "list"
    }
]